Phibro Animal Health Corporation carries a market capitalization of 1.24B, placing it among publicly traded companies globally. Its enterprise value stands at 2.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.24B |
| Enterprise Value | 2.95B |
Phibro Animal Health Corporation currently has 40.56M shares outstanding.
| Shares Outstanding | 40.56M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Phibro Animal Health Corporation trades at a trailing price-to-earnings ratio of 23.54. The price-to-sales ratio is 1.49, and the price-to-book ratio stands at 6.67.
| PE Ratio | 23.54 |
| PS Ratio | 1.49 |
| PB Ratio | 6.67 |
| P/TBV Ratio | 8.29 |
| P/FCF Ratio | 34.20 |
| P/OCF Ratio | 33.90 |
On an enterprise value basis, Phibro Animal Health Corporation trades at an EV/EBITDA multiple of 12.80 and an EV/FCF ratio of 30.29. The EV/Sales ratio of 1.97 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.40 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.97 |
| EV / EBITDA | 12.80 |
| EV / EBIT | 16.40 |
| EV / FCF | 30.29 |
Phibro Animal Health Corporation maintains a current ratio of 3.17, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 217.63, indicating elevated leverage, while an interest coverage ratio of 5.44 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 3.17 |
| Quick Ratio | 1.06 |
| Debt / Equity | 217.63 |
| Debt / EBITDA | 3.42 |
| Interest Coverage | 5.44 |
Phibro Animal Health Corporation posts a return on equity of 31.93 and a return on invested capital of 12.07.
| Return on Equity (ROE) | 31.93 |
| Return on Assets (ROA) | 6.90 |
| Return on Invested Capital (ROIC) | 12.07 |
| Return on Capital Employed (ROCE) | 11.75 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.05 |
Over the trailing twelve months, Phibro Animal Health Corporation has paid 33.62M in income taxes, reflecting an effective tax rate of 26.09.
| Income Tax | 33.62M |
| Effective Tax Rate | 26.09 |
Phibro Animal Health Corporation's stock has gained approximately 24.81603% over the past 52 weeks. The 50-day moving average sits at 41.78, while the 200-day moving average is 43.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | 24.81603% |
| 50-Day Moving Average | 41.78 |
| 200-Day Moving Average | 43.40 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Phibro Animal Health Corporation generated 1.50B in revenue and converted that into 95.23M in net income, yielding earnings per share of 2.33. EBITDA reached 230.54M, while operating income came in at 179.96M.
| Revenue | 1.50B |
| Gross Profit | 488.12M |
| Operating Income | 179.96M |
| Pretax Income | 128.85M |
| Net Income | 95.23M |
| EBITDA | 230.54M |
| EBIT | 179.96M |
| Earnings Per Share (EPS) | 2.33 |
Phibro Animal Health Corporation holds 77.45M in cash and equivalents against 787.44M in total debt, resulting in a net debt position of 680.59M. Total book value stands at 336.12M, with working capital of 612.20M providing operational flexibility.
| Cash & Cash Equivalents | 77.45M |
| Total Debt | 787.44M |
| Net Debt | 680.59M |
| Equity (Book Value) | 336.12M |
| Book Value Per Share | 8.29 |
| Working Capital | 612.20M |
Phibro Animal Health Corporation produced 66.13M in operating cash flow over the past twelve months.
| Operating Cash Flow | 66.13M |
| Capital Expenditures | N/A |
| Free Cash Flow | 66.13M |
| FCF Per Share | 1.63 |
Phibro Animal Health Corporation operates with a gross margin of 32.54, reflecting its pricing power and cost economics. The operating margin of 12.00 and net profit margin of 6.35 provide insight into operational efficiency.
| Gross Margin | 32.54 |
| Operating Margin | 12.00 |
| Pretax Margin | 8.59 |
| Profit Margin | 6.35 |
| EBITDA Margin | 15.37 |
The company's payout ratio of 20.43 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.48 |
| Dividend Yield | N/A |
| Payout Ratio | 20.43 |
| Shareholder Yield | 0.57 |
| FCF Yield | 2.92 |
Phibro Animal Health Corporation posts an Altman Z-Score of 3.68, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.68 |